RxDoctor Payments Data

Katie Inclan, PA

Medical · Glen Dale, WVNPI 1265574438

Payments from drug & device makers

$432in general payments, 2019–2025

Across 25 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$60
  • Novo Nordisk$57
  • AbbVie$54
  • Lilly USA, LLC$36
  • Pfizer$36
  • AstraZeneca$35
  • plus $153 from 7 others

What the payments were for

  • Food & beverage$432100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$432 in reported general payments places this provider in the 40th percentile of 233 medical providers in West Virginia.

See all medical providers in West Virginia

Medicare billing

Part B allowed, 2024
$35,401
Medicare patients
157
Services billed
441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide184$213,857
MounjaroTirzepatide127$133,369
JardianceEmpagliflozin83$74,150
EliquisApixaban75$56,890
JanuviaSitagliptin Phosphate51$47,072
Breo ElliptaFluticasone/Vilanterol39$17,480
LinzessLinaclotide16$15,617
TrulicityDulaglutide14$14,209
Tresiba Flextouch U-200Insulin Degludec17$12,974
Novolog FlexpenInsulin Aspart31$10,444
TrulancePlecanatide14$9,161
Janumet XrSitagliptin Phos/Metformin Hcl11$8,273
Lantus SolostarInsulin Glargine,hum.Rec.Anlog79$7,810
XareltoRivaroxaban13$6,439
DuleraMometasone/Formoterol20$6,343

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$57$213,857184 claims
Lilly USA, LLCMounjaro, Trulicity$36$147,579141 claims
Boehringer IngelheimJardiance$16$74,15083 claims
MerckJanuvia, Janumet Xr, Dulera$27$61,68882 claims
PfizerEliquis$36$56,89075 claims
GSKBreo Ellipta, Anoro Ellipta, Arnuity Ellipta$60$26,93969 claims
AbbVieLinzess, Synthroid$54$20,56597 claims
AstraZenecaSymbicort$35$3,76313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 233 medical providers in West Virginia.

Other medical in Glen Dale

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →